MEHERA HALLIWELL: Open Payments
NPI 1366579138 · GRANADA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,690 in 80 payments from 8 companies in 2025. Trend: 2023 $2,420 · 2024 $2,959 · 2025 $2,690
Food & beverage: $2,580Education: $109
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $648 |
| Teva Pharmaceuticals USA, Inc. | 15 | $514 |
| Otsuka America Pharmaceutical, Inc. | 12 | $416 |
| Alkermes, Inc. | 15 | $399 |
| E.R. Squibb & Sons, L.L.C. | 11 | $337 |
| Neurocrine BioSciences, Inc. | 10 | $198 |
| Janssen Biotech, Inc. | 1 | $123 |
| Axsome Therapeutics, Inc. | 3 | $55 |
Products named: INVEGA SUSTENNA, COBENFY, UZEDY, ARISTADA, INGREZZA, REXULTI, ABILIFY MAINTENA, LYBALVI.
Industry payments across CA — which companies pay providers there.
